Description of the Impact of the Modelo Sentido's® on Adaptive Behaviors in Children With Autism
- Sponsor
- Sentido's CAIP & CICI Organización Terapéutica
- Study ID
- NCT06477666
- Status
- Completed
Conditions
- Adaptive Behaviors
- Autism Spectrum Disorder
- Neurodevelopmental Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 3 Years - 7 Years
- Healthy Volunteers
- Not accepted
Interventions
- Sentido's® Model — BEHAVIORALThe Sentido's® Model is an integrated intervention approach that combines Applied Behavior Analysis (ABA), Ayres Sensory Integration (ASI), and Psychoimmunoendocrinology (PINE) within a transcomplexity theoretical framework. The intervention addresses Bio-Neuro-Sensory-Psycho-Social-Spiritual-Occupational-Nutritional-Ecological dimensions of development through individualized treatment protocols. Sessions are delivered by trained therapists with active family participation in a specialized neurodevelopment center setting. The intervention duration is 14 weeks with protocol-specific scheduling based on individual participant needs.
Study Details
Knowing the impact of the Modelo Sentido´s® (MS) on the gain of adaptive behaviors in children on the autism spectrum (AS) and other associated neurodevelopmental challenges (ANDC), is essential to improve the quality of life of children, families and professionals who live with neurodevelopmental challenges; inform parents about the efficacy and effectiveness of the interventions offered; provide scientific knowledge required by government agencies, public and private policy makers to make informed decisions about which intervention they should support; contribute with a manualized intervention program contextually appropriate to the strengths and challenge within a low- and middle-income country, which can potentially be modified by reverse engineering to apply it to environments that require it in high-income countries. MS is a proposal for understanding and therapeutic intervention on the dimensional complexity involved in the challenges of neurodevelopment. MS provides a clinical practice framework that generates, drives, and sustains interaction and collaboration between disciplines converging in transdisciplinarity. MS promotes understanding, reasoning, and intervention on the Bio-Neuro-Sensory-Psycho-Social-Spiritual-Occupational-Nutritional-Ecological dimensions of childhoods in AS and other ANDC, their significant caregivers and intervening therapists. MS focuses its bases on three evidence-based frameworks: the applied behavior analysis (ABA), sensory integration (SI) and psychoimmunoneuroendocrinology (PINE) correlate of the neurobiology of stress. Which emerge from behavioral sciences, developmental sciences, neurosciences, and stress sciences. Evidence supports that interventions in children with AS beyond addressing core symptoms should focus on outcome measures, such as quality of life and adaptive functioning. MS focuses its programs on supporting and accompaniment to parents and significant caregivers as a fundamental aspect for gaining adaptive behaviors in childhood. MS provides tools that encourage and develop adaptive behaviors in childhood in EA and other ANDC; In turn, MS enhances the families' competencies, confidence, and caring skills towards their child.
Key Dates
- Start date
- Oct 30, 2023
- Status verified
- Aug 2025
- Primary completion
- Jun 7, 2025
- Completion
- Aug 7, 2025
Study Design
- Enrollment
- 24 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Sentido's® Model Intervention GroupSingle intervention group receiving the Sentido's® Model for 14 weeks. Participants are children aged 3-7 years with autism spectrum disorder and associated neurodevelopmental challenges. All participants receive individualized intervention protocols combining ABA, ASI, and PINE approaches with family participation. Sessions are conducted at a specialized neurodevelopment center in Comodoro Rivadavia, Argentina. Following the 14-week active intervention period, participants undergo a 3-week follow-up assessment period without direct intervention to evaluate maintenance of treatment effects.
Primary Outcome Measure
Vineland-3 Adaptive Behavior Composite Score [ Time Frame: Baseline, 14 weeks (post-intervention), and 17 weeks (follow-up) ]
Related Studies
- Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)PHASE2 · Recruiting · Montefiore Medical Center · New York, New York
- Cerebellar Stimulation and Cognitive ControlRecruiting · Krystal Parker, PhD · Iowa City, Iowa
- SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of AutismRecruiting · American Federation of Medical Synergetics · Louisville, Kentucky
- Translating Evidence-based Interventions for ASD: Multi-Level Implementation StrategyEnrolling By Invitation · University of California, Davis · Sacramento, California